But in this case, “them” isn’t the illegal aliens President Trump is so fond of railing about. This “them” is new or mutated ...

Caliber recently launched 4 digital solutions that further strengthen its portfolio and also position the company at the forefront of the Pharma 4.0 ...

Indianapolis has been awash in Big Ten logos amid the conference's basketball tournaments. But Indy is home to another sort ...

Anika announced fourth quarter revenue from continuing operations of $30.6 million increasing 1% compared to the same period ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted ...

President Donald Trump pushed border encounters to historical lows, and did so without signing into law a bipartisan border ...

Topline clinical data of the confirmatory registrational study GLOW2 expected in 1Q 2026. <li /> GLOW2 study design mirrors GLOW1 study, ...

The at-long-last-decision to write his memoirs, was quite a daunting one for General Babangida, who has over the years, ...

In response to rising threats, a local psychotherapist has distributed thousands of whistles, aiming to create safer spaces ...

The company introduced technologies like Next-Generation Sequencing and Sanger Sequencing nearly a decade ago.

Many critical functions of the food division of the Food and Drug Administration have been drastically slowed or entirely stopped since late ...